BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36050601)

  • 21. Knockdown of eukaryotic translation initiation factor 3 subunit B inhibits cell proliferation and migration and promotes apoptosis by downregulating WNT signaling pathway in acute myeloid leukemia.
    Feng Y; Wu L
    Int J Clin Exp Pathol; 2020; 13(1):99-106. PubMed ID: 32055278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eukaryotic translation initiation factor 3B is overexpressed and correlates with deteriorated tumor features and unfavorable survival profiles in cervical cancer patients.
    Zhu P; Tan Q; Jiang W; Ou Y; Xu P; Yuan L
    Cancer Biomark; 2019; 26(2):123-130. PubMed ID: 31322539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of translation initiation factor eIF3b promotes apoptosis in osteosarcoma cells.
    Choi YJ; Lee YS; Lee HW; Shim DM; Seo SW
    Bone Joint Res; 2017 Mar; 6(3):186-193. PubMed ID: 28360085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
    Dar AA; Majid S; Rittsteuer C; de Semir D; Bezrookove V; Tong S; Nosrati M; Sagebiel R; Miller JR; Kashani-Sabet M
    J Natl Cancer Inst; 2013 Mar; 105(6):433-42. PubMed ID: 23365201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
    Xu C; Fan CD; Wang X
    Oncogene; 2015 Jan; 34(3):281-9. PubMed ID: 24413081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells.
    Gao C; Xiao G; Piersigilli A; Gou J; Ogunwobi O; Bargonetti J
    Breast Cancer Res; 2019 Jan; 21(1):5. PubMed ID: 30642351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anaphase-promoting complex/cyclosome is an E3 ubiquitin ligase for Mdm2.
    He Y; Tollini L; Kim TH; Itahana Y; Zhang Y
    Cell Cycle; 2014; 13(13):2101-9. PubMed ID: 24804778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BAP1 antagonizes WWP1-mediated transcription factor KLF5 ubiquitination and inhibits autophagy to promote melanoma progression.
    Jia X; Chen H; Ren Y; Dejizhuoga ; Gesangyuzhen ; Gao N; Feng H; Huang W; Liao Y; Yu H
    Exp Cell Res; 2021 May; 402(1):112506. PubMed ID: 33516665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of eukaryotic initiation factor 3B suppresses proliferation and promotes apoptosis of chronic myeloid leukemia cells.
    Huang L; He K; Wang J; Yan J; Jiang Y; Wei Z; Zhang J; Li G; Sheng L
    Adv Clin Exp Med; 2019 Dec; 28(12):1639-1645. PubMed ID: 31778600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma.
    Worrall C; Suleymanova N; Crudden C; Trocoli Drakensjö I; Candrea E; Nedelcu D; Takahashi SI; Girnita L; Girnita A
    Oncogene; 2017 Jun; 36(23):3274-3286. PubMed ID: 28092675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5-MDM2-p53 pathway.
    Li Y; Zhou Y; Li B; Chen F; Shen W; Lu Y; Zhong C; Zhang C; Xie H; Katanaev VL; Jia L
    Oncogene; 2020 Mar; 39(13):2741-2755. PubMed ID: 32005977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation.
    Xu C; Shen Y; Shi Y; Zhang M; Zhou L
    Cancer Cell Int; 2022 Apr; 22(1):161. PubMed ID: 35459206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction with AEG-1 and MDM2 is associated with glioma development and progression and correlates with poor prognosis.
    Ding Z; Zhang Z; Jin X; Chen P; Lv F; Liu D; Shen Y; Li Y; Gu X
    Cell Cycle; 2019 Jan; 18(2):143-155. PubMed ID: 30560724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma.
    Zang Y; Zhang X; Yan L; Gu G; Li D; Zhang Y; Fang L; Fu S; Ren J; Xu Z
    J Cancer; 2017; 8(15):3049-3061. PubMed ID: 28928896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E2F1-dependent oncogenic addiction of melanoma cells to MDM2.
    Verhaegen M; Checinska A; Riblett MB; Wang S; Soengas MS
    Oncogene; 2012 Feb; 31(7):828-41. PubMed ID: 21743494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure of the RNA recognition motif of yeast translation initiation factor eIF3b reveals differences to human eIF3b.
    Khoshnevis S; Neumann P; Ficner R
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9.
    Zhang Y; Hou J; Shi S; Du J; Liu Y; Huang P; Li Q; Liu L; Hu H; Ji Y; Guo L; Shi Y; Liu Y; Cui H
    Cell Death Dis; 2021 Jan; 12(1):118. PubMed ID: 33483464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EIF3H knockdown inhibits malignant melanoma through regulating cell proliferation, apoptosis and cell cycle.
    Zheng W; Li Y; Su Z; Zhang J; Shi F; Liang W
    Exp Cell Res; 2021 May; 402(1):112488. PubMed ID: 33508274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
    Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
    Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.